Skip To Content

News & Events

Given the activity level of our attorneys, we are confident in showcasing the various matters that our clients have given us the privilege to work on and approved to post here.

Posts

  • July 23 2023

    Tivic Health Systems, Inc. announced the closing of its Public Offering in the amount of $2,100,000. EG&S acted as counsel to the Placement Agent.

  • July 23 2023

    PainReform Ltd. announced the closing of its Registered Direct offering in the amount of $1,500,000. EG&S acted as counsel to the Placement Agent.

  • July 22 2023

    PainReform Ltd. announced the closing of its Registered Direct offering in the amount of $1,500,000. EG&S acted as counsel to the Placement Agent.

  • July 22 2023

    First Wave BioPharma, Inc. announced the closing of its Public Offering in the amount of $2,100,000. EG&S acted as counsel to the Placement Agent.

  • July 21 2023

    Asensus Surgical, Inc. announced the closing of its Registered Direct offering in the amount of $10,000,000. EG&S acted as counsel to the Placement Agent.

  • July 20 2023

    PainReform Ltd. announced the closing of its Registered Direct offering in the amount of $2,700,000. EG&S acted as counsel to the Placement Agent.

  • July 20 2023

    Tivic Health Systems, Inc. announced the closing of its Public Offering in the amount of $2,100,000. EG&S acted as counsel to the Placement Agent.

  • July 19 2023

    Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company for liver, metabolic and fibrotic diseases, announced the closing of its follow-on offering in the amount of $7,000,000. EGS acted as counsel to Maxim Group LLC, the sole placement agent in connection with the offering.

“It’s with genuine appreciation to all of our clients that we are in a position to achieve and maintain our leadership position in so many areas.”